EP 1652534 A3 20070502 - Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer
Title (en)
Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer
Title (de)
Zusammensetzung, welche den Koagulationsfaktor VIII beinhalted; Verfahren zu deren Herstellung und die Benutzung eines oberflächenaktiven Stoffes als Stabilisator
Title (fr)
Composition comprenant une formulation d'un facteur de coagulation VIII, procédé pour sa préparation et utilisation d'un agent tensioactif comme stabilisateur
Publication
Application
Priority
- EP 99121997 A 19931001
- EP 93923080 A 19931001
- SE 9202878 A 19921002
- SE 9301580 A 19930507
- SE 9302006 A 19930611
Abstract (en)
[origin: EP1652534A2] This invention relates to a composition comprising coagulation facto Vlll and a non-ionic surfactant as stabilizer and a process for its preparation.
IPC 8 full level
A61K 35/16 (2006.01); A61K 47/02 (2006.01); A61K 9/127 (2006.01); A61K 9/19 (2006.01); A61K 38/37 (2006.01); A61K 47/18 (2006.01); A61K 47/26 (2006.01); C07K 14/755 (2006.01); C12N 9/96 (2006.01); A61K 9/107 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP US)
A61K 9/0019 (2013.01 - EP US); A61K 9/19 (2013.01 - EP US); A61K 38/37 (2013.01 - EP US); A61K 47/02 (2013.01 - EP US); A61K 47/183 (2013.01 - EP US); A61K 47/26 (2013.01 - EP US); A61K 47/42 (2013.01 - EP US); A61P 7/04 (2018.01 - EP); C07K 14/755 (2013.01 - EP US); C12N 9/96 (2013.01 - EP US); A61K 9/1075 (2013.01 - EP US); Y10S 530/83 (2013.01 - EP US)
Citation (search report)
- [XY] EP 0209041 A2 19870121 - ARMOUR PHARMA [US]
- [DY] EP 0268110 A1 19880525 - CETUS CORP [US]
- [DY] US 4165370 A 19790821 - COVAL MYER LOUIS
- [DY] WO 8909614 A1 19891019 - GENENTECH INC [US]
- [PX] EP 0508194 A1 19921014 - BEHRINGWERKE AG [DE]
- [DA] WO 9110439 A1 19910725 - OCTAPHARMA AG [CH], et al
- [X] PIET M P J ET AL: "THE USE OF TRI(N-BUTYL)PHOSPHATE DETERGENT MIXTURES TO INACTIVATE HEPATITIS VIRUSES AND HUMAN IMMUNODEFICIENCY VIRUS IN PLASMA AND PLASMA'S SUBSEQUENT FRACTIONATION", TRANSFUSION, AMERICAN ASSOCIATION OF BLOOD BANKS, BETHESDA, MD, US, vol. 30, no. 7, 1990, pages 591 - 598, XP001021759, ISSN: 0041-1132
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9407510 A1 19940414; AT E198277 T1 20010115; AT E316981 T1 20060215; AU 5288393 A 19940426; AU 677797 B2 19970508; CA 2124690 A1 19940414; CA 2124690 C 20070911; CZ 132894 A3 19941116; CZ 290342 B6 20020717; DE 69329795 D1 20010201; DE 69329795 T2 20010705; DE 69333974 D1 20060413; DE 69333974 T2 20060803; DK 0627924 T3 20010430; EP 0627924 A1 19941214; EP 0627924 B1 20001227; EP 1016673 A1 20000705; EP 1016673 B1 20060201; EP 1652534 A2 20060503; EP 1652534 A3 20070502; ES 2154650 T3 20010416; FI 111443 B 20030731; FI 942573 A0 19940601; FI 942573 A 19940601; GR 3035472 T3 20010531; HU 211670 A9 19951228; HU 220194 B 20011128; HU 9401382 D0 19940829; HU T70330 A 19950928; JP 3905921 B2 20070418; JP H07501560 A 19950216; KR 100303872 B1 20011122; MX 9306133 A 19940429; NO 942033 D0 19940601; NO 942033 L 19940601; NZ 256921 A 19960528; PT 627924 E 20010531; SK 282483 B6 20020205; SK 65994 A3 19950308; US 5733873 A 19980331; US 5919766 A 19990706
DOCDB simple family (application)
SE 9300793 W 19931001; AT 93923080 T 19931001; AT 99121997 T 19931001; AU 5288393 A 19931001; CA 2124690 A 19931001; CZ 132894 A 19931001; DE 69329795 T 19931001; DE 69333974 T 19931001; DK 93923080 T 19931001; EP 06001883 A 19931001; EP 93923080 A 19931001; EP 99121997 A 19931001; ES 93923080 T 19931001; FI 942573 A 19940601; GR 20010400311 T 20010223; HU 9401382 A 19931001; HU 9500473 P 19950628; JP 50895794 A 19931001; KR 19940701858 A 19940602; MX 9306133 A 19931001; NO 942033 A 19940601; NZ 25692193 A 19931001; PT 93923080 T 19931001; SK 65994 A 19931001; US 24426694 A 19940520; US 86319897 A 19970527